background
acutephas
protein
app
sensit
marker
inflamm
serum
creactiv
protein
crp
recent
shown
use
diagnost
marker
dog
bacteri
pneumonia
bp
human
communityacquir
pneumonia
app
also
great
util
followup
marker
aid
assess
treatment
respons
object
aim
studi
investig
applic
app
marker
treatment
respons
dog
bp
anim
nineteen
dog
diagnos
bp
healthi
dog
method
studi
conduct
prospect
longitudin
observ
studi
serum
crp
serum
amyloid
saa
haptoglobin
concentr
follow
natur
cours
bp
normal
serum
crp
use
guid
durat
antibiot
treatment
treatment
stop
day
crp
normal
dog
surviv
discharg
dog
treat
accord
convent
recommend
result
measur
app
initi
significantli
increas
magnitud
increas
correl
diseas
sever
creactiv
protein
saa
concentr
decreas
rapidli
initi
antimicrobi
treatment
normal
serum
crp
use
guid
durat
antibiot
treatment
treatment
durat
significantli
p
decreas
without
increas
number
relaps
conclus
clinic
import
serum
crp
saa
reflect
recoveri
process
well
therefor
may
use
marker
treatment
respons
accord
result
normal
serum
crp
may
use
guid
durat
antibiot
treatment
dog
bp
b
acteri
pneumonia
bp
acquir
inflamm
lower
airway
lung
parenchyma
secondari
bacteri
infect
clinic
characterist
microbiolog
find
dog
bp
well
describ
howev
inform
concern
normal
clinic
radiograph
find
recoveri
process
guidelin
assess
optim
durat
antibiot
treatment
bp
still
limit
acutephas
protein
app
group
blood
protein
mainli
produc
liver
part
innat
host
defens
system
app
involv
protect
infect
well
regul
immun
respons
inflamm
especi
earli
phase
injuri
major
posit
app
dog
creactiv
protein
crp
serum
amyloid
saa
low
serum
concentr
healthi
dog
serum
concentr
crp
saa
increas
markedli
within
first
hour
inflammatori
stimuli
normal
quickli
recoveri
period
app
certain
advantag
diseas
monitor
compar
cbc
number
blood
leukocyt
larg
affect
extravas
pulmonari
parenchyma
acut
bp
wherea
app
increas
consist
increas
inflammatori
stimuli
minor
moder
posit
app
haptoglobin
hp
show
gradual
increas
decreas
acutephas
respons
apr
product
plasma
protein
socal
neg
app
albumin
transferrin
decreas
apr
nonspecif
biomark
inflamm
increas
serum
concentr
crp
saa
hp
observ
dog
varieti
infecti
immunemedi
neoplast
diseas
despit
nonspecif
natur
app
serum
crp
use
discrimin
diseas
process
bp
pulmonari
diseas
app
shown
decreas
initi
success
treatment
addit
increas
serum
crp
longterm
followup
dog
leishmaniasi
immunemedi
polyarthr
predict
relaps
clinic
diseas
util
crp
saa
possibl
prognost
biomark
also
studi
dog
studi
conclud
serum
crp
saa
concentr
present
could
predict
clinic
outcom
howev
persist
increas
serum
crp
hour
treatment
correl
poor
outcom
serum
crp
wide
studi
human
communityacquir
pneumonia
cap
use
diagnost
followup
biomark
recommend
current
treatment
guidelin
bacteri
pneumonia
current
treat
markedli
longer
antimicrobi
cours
cap
effect
mean
estim
optim
treatment
durat
lack
biomarkerguid
antimicrobi
treatment
studi
human
cap
procalcitonin
pct
novel
inflammatori
biomark
indic
pctguid
antibiot
use
decreas
durat
antimicrobi
treatment
without
increas
incid
complic
similar
studi
assess
crpguid
antimicrobi
use
human
cap
lack
serum
crp
shown
use
decreas
durat
antimicrobi
treatment
human
neonat
septicemia
without
increas
incid
complic
aim
studi
describ
chang
clinic
variabl
thorac
radiograph
app
natur
cours
bp
dog
well
compar
variabl
dog
less
sever
bp
requir
day
hospit
lsbp
sever
bp
requir
day
hospit
msbp
addit
purpos
studi
provid
inform
concern
applic
app
assess
treatment
respons
investig
whether
serum
crp
measur
aid
estim
antimicrobi
treatment
durat
dog
bp
studi
conduct
prospect
longitudin
observ
studi
privat
own
dog
diagnos
bp
march
decemb
veterinari
teach
hospit
univers
helsinki
elig
inclus
studi
dog
known
suspect
concurr
infecti
inflammatori
neoplast
diseas
capabl
increas
app
concentr
exclud
studi
dog
known
excess
endogen
glucocorticoid
glucocorticoid
medic
week
bp
exclud
hp
measur
pregnant
lactat
bitch
puppi
month
age
also
exclud
privat
own
blood
donor
dog
recruit
healthi
control
app
measur
dog
sign
ill
normal
physic
examin
find
well
normal
hematolog
biochemistri
find
full
clinic
examin
perform
thorac
radiograph
well
blood
fecal
respiratori
sampl
obtain
present
previous
describ
thorac
radiograph
assess
radiologist
akl
blind
patient
data
bacteri
pneumonia
diagnos
typic
acut
sign
least
follow
fever
lethargi
dyspnea
tachypnea
cough
observ
thorac
radiograph
find
compat
bp
ie
alveolar
pattern
moder
sever
bronchointerstiti
interstiti
pattern
bacteri
origin
demonstr
respiratori
cytolog
bacteri
cultur
previous
describ
postmortem
examin
perform
dog
die
euthan
hospit
confirm
diagnosi
bp
initi
examin
dog
examin
daili
hospit
clinic
examin
individu
chosen
method
includ
blood
test
thorac
imag
followup
visit
interv
discharg
last
followup
visit
schedul
week
antimicrobi
treatment
conclud
clinic
examin
perform
followup
visit
blood
sampl
hematolog
app
measur
arteri
blood
ga
analysi
obtain
thorac
radiograph
repeat
owner
contact
week
last
followup
visit
obtain
inform
possibl
relaps
initi
antimicrobi
treatment
chosen
empir
cover
common
caus
organ
bp
later
bacteri
cultur
antimicrobi
suscept
result
avail
treatment
regimen
reevalu
necessari
chang
made
accord
cultur
result
hospit
antimicrobi
administr
iv
po
treatment
continu
discharg
dog
discharg
requir
oxygen
supplement
capabl
maintain
normal
hydrat
nutrit
po
begin
trial
durat
antimicrobi
treatment
follow
convent
recommend
dog
treat
week
week
beyond
resolut
alveolar
densiti
thorac
radiograph
antimicrobi
treatment
dog
enter
studi
discontinu
day
serum
crp
return
normal
mgl
antibiot
treatment
discontinu
crpguid
approach
owner
consent
hematolog
serum
biochemistri
arteri
blood
ga
analysi
blood
cultur
fecal
analysi
along
cytolog
microbiolog
analysi
respiratori
sampl
perform
previous
describ
coagul
paramet
prothrombin
time
pt
activ
partial
thromboplastin
time
aptt
evalu
commerci
test
kit
dog
b
serum
sampl
obtain
app
analysi
either
immedi
analyz
store
analyz
crp
analyz
magnet
permeabilitybas
immunoassay
c
valid
dog
creactiv
protein
valu
detect
limit
crp
assay
mgl
set
mgl
result
upper
detect
limit
assay
mgl
set
mgl
crp
ratio
crp
concentr
hour
divid
initi
concentr
describ
decreas
crp
earli
recoveri
calcul
initi
treatment
dog
sampl
avail
time
point
question
sampl
saa
analysi
sent
dri
ice
extern
laboratori
measur
autom
e
latex
agglutin
test
f
valid
dog
haptoglobin
measur
commerci
colorimetr
method
g
valid
dog
normal
test
perform
shapirowilk
test
normal
normal
qq
plot
differ
dog
lsbp
msbp
well
dog
escherichia
coliinduc
bp
bp
caus
organ
evalu
independ
sampl
student
ttest
normal
distribut
variabl
mannwhitney
utest
nonnorm
distribut
variabl
mannwhitney
utest
also
use
evalu
whether
differ
bronchoalveolar
lavag
fluid
balf
transtrach
wash
ttw
fluid
differenti
cell
count
whether
durat
antimicrobi
treatment
differ
dog
crpguid
convent
treatment
initi
serum
crp
saa
hp
albumin
concentr
compar
among
group
healthi
dog
well
dog
day
day
hospit
mannwhitney
utest
bonferroni
correct
use
pairwis
comparison
control
familywis
error
rate
correl
serum
app
clinic
variabl
bodi
temperatur
respiratori
rate
partial
pressur
arteri
oxygen
pao
carbon
dioxid
paco
alveolararteri
gradient
aao
blood
leukocyt
paramet
balf
cytolog
well
durat
clinic
sign
durat
hospit
assess
spearman
correl
coeffici
pvalu
consid
statist
signific
mean
curv
fig
calcul
randomeffect
analysi
varianc
regress
model
anova
crp
saa
logarithm
transform
comput
normal
distribut
fit
valu
estim
model
transform
back
origin
scale
repres
geometr
mean
respons
time
hp
pao
absolut
valu
use
respons
mean
curv
comput
directli
fit
valu
explanatori
variabl
model
includ
fix
effect
group
day
interact
group
day
random
effect
dog
dog
day
statist
analys
perform
commerci
statist
softwar
h
j
studi
approv
ethic
committe
univers
helsinki
owner
consent
obtain
owner
dog
particip
nineteen
dog
diagnos
bp
includ
privat
own
healthi
blood
donor
dog
chosen
control
app
measur
age
bodi
weight
sex
distribut
dog
particip
studi
present
tabl
dog
repres
variou
breed
without
overrepresent
singl
breed
dog
present
acut
emerg
case
vari
sever
fifteen
dog
requir
hospit
one
dog
die
consequ
sever
bp
despit
fact
bacteria
isol
suscept
antibiot
use
one
dog
euthan
consequ
refractori
bp
caus
multiresist
e
coli
none
owner
refus
hospit
select
euthanasia
financi
reason
concurr
diseas
process
possibl
predispos
develop
bp
identifi
dog
parainfluenza
respiratori
corona
viru
infect
advanc
chronic
bronchiti
tabl
microbiolog
find
respiratori
sampl
bronchoalveolar
lavag
fluid
n
transtrach
wash
fluid
n
transthorac
fineneedl
aspir
n
fresh
sputum
sampl
n
blood
cultur
dog
bacteri
pneumonia
n
clinic
data
well
durat
clinic
sign
hospit
present
tabl
fecal
analys
avail
dog
sampl
neg
lungworm
intestin
parasit
prothrombin
time
aptt
measur
dog
differ
occas
either
present
hospit
prothrombin
time
normal
measur
mildli
prolong
aptt
note
dog
dog
e
coli
detect
respiratori
sampl
one
dog
hospit
day
surviv
hospit
discharg
serum
crp
saa
hp
concentr
present
figur
alveolar
lung
pattern
detect
dog
involv
singl
lobe
dog
multipl
lobe
dog
patchi
alveolar
pattern
involv
sever
lobe
found
dog
cranial
middl
lobe
often
affect
moderatetosever
interstiti
bronchointerstiti
lung
pattern
identifi
dog
present
alveolar
pattern
multipl
lobe
present
detect
dog
lsbp
dog
msbp
alveolar
pattern
found
dog
resolv
median
day
iqr
day
dog
clear
alveolar
infiltr
day
followup
visit
week
discontinu
antibiot
dog
still
mildtomoder
bronchial
bronchointerstiti
interstiti
pattern
thorac
radiograph
bronchoalveolar
lavag
fluid
retriev
ttw
perform
bal
ttw
avail
mainli
due
small
size
patient
sever
bp
transthorac
aspir
tta
collect
fresh
sputum
sampl
dog
microbiolog
analysi
perform
dog
result
present
tabl
cytolog
analysi
perform
dog
cytolog
perform
ttw
sampl
result
cytolog
analys
present
tabl
balf
ttw
fluid
cytolog
differ
significantli
cell
percentag
apart
percentag
epitheli
cell
median
balf
iqr
versu
median
ttw
fluid
iqr
p
combin
result
present
sampl
techniqu
cytolog
tta
n
fresh
sputum
n
sampl
consist
markedli
increas
number
neutrophil
intracellular
bacteria
abund
bacteri
growth
detect
sampl
diagnosi
bp
addit
confirm
postmortem
examin
dog
sputum
sampl
dog
tta
sampl
dog
e
coli
caus
agent
requir
significantli
p
longer
hospit
median
day
rang
compar
dog
caus
bacteria
median
day
rang
dog
e
coliinduc
bp
die
euthan
diseas
sever
dog
surviv
discharg
receiv
antibiot
accord
convent
recommend
median
durat
treatment
day
iqr
day
crp
use
determin
durat
treatment
less
sever
bp
msbp
observ
dog
respect
antimicrobi
treatment
discontinu
day
crp
normal
dog
median
durat
treatment
day
iqr
day
less
sever
bp
msbp
observ
dog
respect
treatment
guid
crp
median
day
significantli
shorter
p
convent
treatment
median
day
sixteen
dog
clinic
sign
find
suggest
bp
relaps
followup
visit
week
antibiot
discontinu
followup
phone
call
week
followup
visit
one
dog
treat
convent
relaps
bp
antibiot
discontinu
cush
diseas
later
found
predispos
factor
bacteria
suscept
initi
chosen
antimicrobi
detect
dog
dog
bacteri
growth
detect
therefor
antimicrobi
suscept
could
address
dog
treat
accord
convent
recommend
treat
crp
guidanc
measur
posit
app
significantli
increas
dog
bp
present
compar
healthi
control
find
agreement
previou
report
describ
crp
saa
dog
bp
haptoglobin
concentr
report
previous
signific
increas
serum
hp
report
hour
inflammatori
stimulu
increas
concentr
also
expect
bp
howev
must
emphas
app
highli
nonspecif
inflammatori
marker
addit
bp
increas
concentr
may
encount
varieti
diseas
process
expect
posit
app
crp
saa
hp
correl
posit
howev
neg
correl
albumin
occur
comparison
like
due
long
halflif
albumin
result
late
respons
notic
acut
bp
serum
app
concentr
present
differ
significantli
dog
lsbp
msbp
addit
serum
crp
saa
hp
present
correl
significantli
marker
diseas
sever
arteri
pao
durat
hospit
initi
serum
crp
saa
hp
concentr
dog
bp
therefor
may
use
indic
diseas
sever
similar
observ
made
studi
describ
crp
human
patient
cap
creactiv
protein
saa
rapidli
decreas
initi
treatment
fig
b
find
indic
crp
saa
use
marker
treatment
respons
haptoglobin
show
gradual
increas
decreas
therefor
reflect
clinic
recoveri
well
crp
saa
wider
rang
concentr
magnitud
chang
pronounc
saa
compar
crp
saa
might
better
diagnost
followup
marker
crp
dog
bp
alreadi
suggest
recent
studi
compar
crp
saa
diagnost
marker
system
inflamm
healthi
hosp
hosp
creactiv
protein
continu
increas
within
first
hour
dog
unexpect
dog
bp
present
acut
crp
known
reach
peak
concentr
approxim
hour
onset
inflammatori
stimulu
consequ
meaning
interpret
possibl
crp
decreas
earli
hour
initi
treatment
howev
decreas
serum
crp
expect
hour
initi
success
treatment
failur
show
decreas
associ
poor
prognosi
dog
system
inflammatori
condit
consecut
measur
crp
found
use
human
cap
magnitud
crp
decreas
day
shown
prognost
valu
connect
also
shown
pattern
serum
crp
concentr
outcom
human
patient
persist
high
crp
socal
nonrespons
increas
serum
crp
initi
decreas
socal
biphas
respons
first
day
hospit
poor
prognosi
studi
crp
ratio
describ
magnitud
decreas
hour
correl
durat
hospit
find
could
consequ
small
number
sampl
avail
crp
measur
hour
dog
msbp
still
aliv
hospit
hour
present
anoth
limit
concern
method
use
crp
measur
upper
detect
limit
assay
use
mgl
measur
exceed
concentr
set
mgl
underestim
increas
serum
crp
shown
serum
crp
increas
markedli
mgl
dog
aspir
pneumonia
approach
affect
interpret
crp
ratio
recoveri
process
limit
make
interpret
crp
ratio
studi
less
inform
one
dog
euthan
refractori
bp
biphas
crp
respons
pattern
similar
describ
connect
poor
prognosi
human
cap
regard
variabl
dog
msbp
character
pronounc
left
shift
lymphopenia
significantli
hypoxem
respiratori
sampl
dog
msbp
character
significantli
pronounc
neutrophilia
eosinopenia
lymphopenia
compar
dog
lsbp
variabl
therefor
could
use
earli
marker
aid
identif
dog
sever
cours
bp
escherichia
coli
caus
agent
addit
correl
sever
cours
bp
moreov
coagul
abnorm
detect
dog
msbp
caus
e
coli
find
like
due
endotoxin
produc
e
coli
affect
hemodynam
blood
clot
cellular
humor
immun
similar
find
increas
diseas
sever
describ
e
coliinduc
cap
addit
prolong
aptt
correl
wors
prognosi
human
dog
system
inflamm
sepsi
initi
radiograph
find
consist
previous
report
find
dog
bp
resolut
alveolar
lung
pattern
follow
hospit
followup
visit
howev
thorac
radiograph
repeat
daili
exact
time
point
resolut
could
determin
alveolar
infiltr
resolv
rel
rapidli
studi
dog
clear
alveolar
infiltr
day
compar
studi
human
human
patient
cap
clearanc
radiograph
tabl
comparison
demograph
clinic
respiratori
cytolog
find
present
dog
less
sever
bacteri
pneumonia
bp
requir
day
hospit
n
sever
bp
requir
day
hospit
n
includ
mortal
infiltr
day
day
also
shown
radiograph
normal
lag
behind
clinic
cure
assess
physician
cap
current
research
abl
show
benefit
routin
repeat
thorac
radiograph
clinic
recoveri
repeat
thorac
radiograph
hospit
therefor
recommend
patient
uncompl
recoveri
addit
inform
gain
thorac
radiograph
especi
clearanc
alveolar
infiltr
minim
studi
dog
otherwis
satisfactori
clinic
recoveri
antimicrobi
treatment
current
recommend
week
week
beyond
resolut
radiograph
chang
markedli
shorter
antimicrobi
cours
use
cap
antibiot
recommend
day
case
mildtomoder
cap
use
biomark
prove
use
determin
optim
treatment
durat
publish
clinic
studi
exist
address
optim
durat
antimicrobi
dog
bp
current
recommend
may
overestim
treatment
durat
need
especi
uncompl
case
consid
varieti
infecti
agent
individu
differ
interact
microb
host
immun
system
need
also
exist
dog
bp
custom
antibiot
treatment
durat
accord
diseas
sever
respons
rate
studi
normal
crp
use
guid
durat
antimicrobi
treatment
dog
result
significantli
decreas
treatment
durat
compar
convent
treat
dog
would
ideal
random
chosen
treatment
regimen
stratifi
random
accord
diseas
sever
instead
convent
treatment
use
begin
studi
previou
inform
applic
crp
predict
treatment
durat
lack
clinic
experi
gain
serum
crp
found
reflect
recoveri
process
well
consid
safe
stop
administ
antibiot
crp
normal
end
antimicrobi
point
crp
normal
still
consid
prematur
increas
safeti
antimicrobi
administ
day
crp
normal
relaps
bp
note
dog
receiv
crpguid
cours
antibiot
therefor
approach
appear
safe
howev
incid
relaps
low
group
studi
abl
identifi
optim
end
point
antimicrobi
treatment
even
shorter
cours
use
crpguid
group
may
suffici
dog
bp
addit
small
number
dog
lack
random
limit
larger
random
studi
warrant
conclus
dog
bp
significantli
increas
serum
crp
saa
hp
present
crp
saa
decreas
rapidli
initi
treatment
reflect
recoveri
process
well
crp
normal
use
guid
durat
antibiot
treatment
treatment
durat
significantli
decreas
without
increas
number
relaps
addit
support
inform
may
found
onlin
support
inform
tab
articl
tabl
respiratori
sampl
techniqu
inform
treatment
outcom
prior
antimicrobi
treatment
bacteri
cultur
antimicrobi
suscept
result
well
inform
antimicrobi
treatment
regimen
individu
dog
n
bacteri
pneumonia
